- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Collaborators
- Suppliers
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- Research centres
- People
- Alistair Brown
- Anne-Laure Puaux
- Assoc Prof Joanna Groom
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Alyssa Barry
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Daniel Gray
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Ethan Goddard-Borger
- Associate Professor Gemma Kelly
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeanne Tie
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor John Wentworth
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Matthew Ritchie
- Associate Professor Melissa Call
- Associate Professor Melissa Davis
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Peter Czabotar
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Sandra Nicholson
- Associate Professor Seth Masters
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Tracy Putoczki
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Belinda Phipson
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gwo Yaw Ho
- Dr Hamish King
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Kelly Rogers
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Nadia Davidson
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Rory Bowden
- Dr Samir Taoudi
- Dr Shabih Shakeel
- Dr Shalin Naik
- Dr Sheau Wen Lok
- Dr Stephin Vervoort
- Dr Yunshun Chen
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Mark Eaton
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Lew
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor James McCarthy
- Professor James Murphy
- Professor Jane Visvader
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leanne Robinson
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marc Pellegrini
- Professor Marco Herold
- Professor Marnie Blewitt
- Professor Melanie Bahlo
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Sant-Rayn Pasricha
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Papenfuss
- Professor Wai-Hong Tham
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Clinician-scientist training
- Undergraduate
- Student research projects
- A new regulator of 'stemness' to create dendritic cell factories for immunotherapy
- Advanced imaging interrogation of pathogen induced NETosis
- Cancer driver deserts
- Cryo-electron microscopy of Wnt signalling complexes
- Deciphering the heterogeneity of breast cancer at the epigenetic and genetic levels
- Developing drugs to block malaria transmission
- Developing new computational tools for CRISPR genomics to advance cancer research
- Developing novel antibody-based methods for regulating apoptotic cell death
- Discovering novel paradigms to cure viral and bacterial infections
- Discovery and targeting of novel regulators of transcription
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Do membrane forces govern assembly of the deadly apoptotic pore?
- Doublecortin-like kinases, drug targets in cancer and neurological disorders
- E3 ubiquitin ligases in neurodegeneration, autoinflammation and cancer
- Engineering improved CAR-T cell therapies
- Epigenetic biomarkers of tuberculosis infection
- Exploiting cell death pathways in regulatory T cells for cancer immunotherapy
- Finding treatments for chromatin disorders of intellectual disability
- Functional epigenomics in human B cells
- Genomic rearrangement detection with third generation sequencing technology
- How does DNA damage shape disease susceptibility over a lifetime?
- How does DNA hypermutation shape the development of solid tumours?
- How platelets prevent neonatal stroke
- Human lung protective immunity to tuberculosis
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigating the role of dysregulated Tom40 in neurodegeneration
- Investigating the role of mutant p53 in cancer
- Lupus: proteasome inhibitors and inflammation
- Machine learning methods for somatic genome rearrangement detection
- Malaria: going bananas for sex
- Measurements of malaria parasite and erythrocyte membrane interactions using cutting-edge microscopy
- Measuring susceptibility of cancer cells to BH3-mimetics
- Minimising rheumatic adverse events of checkpoint inhibitor cancer therapy
- Mutational signatures of structural variation
- Naturally acquired immune response to malaria parasites
- Predicting the effect of non-coding structural variants in cancer
- Revealing the epigenetic origins of immune disease
- Reversing antimalarial resistance in human malaria parasites
- Structural and functional analysis of DNA repair complexes
- Targeting human infective coronaviruses using alpaca antibodies
- Towards targeting altered glial biology in high-grade brain cancers
- Uncovering the real impact of persistent malaria infections
- Understanding Plasmodium falciparum invasion of red blood cells
- Understanding how malaria parasites sabotage acquisition of immunity
- Understanding malaria infection dynamics
- Understanding the mechanism of type I cytokine receptor activation
- Unveiling the heterogeneity of small cell lung cancer
- Using alpaca antibodies to understand malaria invasion and transmission
- Using combination immunotherapy to tackle heterogeneous brain tumours
- Using intravital microscopy for immunotherapy against brain tumours
- Using nanobodies to cross the blood brain barrier for drug delivery
- Using structural biology to understand programmed cell death
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Lilly Backshell
- Megan Kent
- Naomi Jones
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Wayne Cawthorne
- Wil Lehmann
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- Learning Hub
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- WEHI.TV
Rima Darwiche
Meet Rima Darwiche, Founder and Chief Executive Officer at Central Pharmacy Logistics, Australia’s first licenced service providing Direct To Patient investigational products for clinical drug trials.
Rima joined WEHI in 1998, undertaking her honours year with Professor Thomas Kay in the autoimmunity division. “I thoroughly enjoyed the experience and after completing my degree, I worked as a research assistant in his lab for about seven years.”
Tunnel hoardings that paid tribute to the workers of
the Parkville Medical Precinct in September 2021
In 2014, Rima returned to WEHI as a Clinical Research Manager, where she oversaw a range of clinical trials and was responsible for managing the provision of investigational products to the patient.
“It was an area I became very interested in. I noticed many trials had trouble recruiting patients, resulting in delays to get the research trials underway and it was commonplace to see wastage of investigational products for a variety of reasons.”
It was at a conference in the USA in 2015 that Rima had a ‘lightbulb moment’ after attending several talks around an emerging ‘Direct To Patient’ (DTP) model. The decentralised model of clinical trials, or DTP, provides an alternative to the traditional trial, which involves the patient going into a hospital.
This model ultimately leads to a higher patient retention rate as the convenience means participants are more willing to stay committed. Higher retention means greater amounts of data, earlier trial completion and significant cost savings.
“I knew this model would work well in Australia and overcome many of the issues I’d seen during my time managing trials. I returned here on a mission, and immediately begun feasibility research and planning,” says Rima.
Fast forward to January 2020 when Rima officially launched Central Pharmacy Logistics (CPL) Australia.
“As a start-up in clinical trials, every step along the way has involved milestones and turning points,” says Rima.
“Firstly, it was getting licenced by the Pharmacy Authority to send investigational products to a patient’s home.
“Shortly after launching, the COVID-19 pandemic unfolded – it was such a frightening and uncertain time.
The silver lining for my new business was that the DTP model became in demand, as hospitals restricted access to minimise the risk of a COVID outbreak. We couldn’t build the facility fast enough to begin work for clients and sponsors.”
A huge milestone for CPL has been the recent Good Manufacturing Practice (GMP) license awarded by Therapeutic Goods Administration.
In early May, Rima travelled to San Antonio, Texas, as an invited speaker at the Global Clinical Supplies Group 2022 Conference, where she delivered a talk on Decentralised Trials and DTP clinical trials in the Asia-Pacific
“Australia is fast becoming the world’s centre stage for clinical trials due to our pragmatic regulatory system, best-in-class health care system and patient pool diversity. The last time I was at this conference was 3 years ago as a delegate. How life has its interesting twists and turns.”
Six questions with Rima …
What did you find out about yourself during lockdown?
Since COVID-19 I have found a love for camping. I’ve enjoyed camping around Victoria and it’s helped me manage stress and the pressures of the past couple of years. I have discovered that being out in nature is what I really love, including walking barefoot and connecting with the environment.
Which living person do you most admire?
Malcolm Turnbull for being a nice and good human while trying to manage the challenges of being a politician at the same time – that would have been a tough gig. My other favourite living person is Norman Swan as he speaks sense during the pandemic while our Government confused and divided the Country. I also forgot to mention Professor Marc Pellegrini, my boss and absolute support at WEHI and my current career.
Your guilty streaming pleasure?
I don’t have a great deal of spare time; however I did binge on Handmaids Tale and The Crown during lockdown! I also love watching anything to do with space and flight.
What are you reading/listening to?
Love listening to Ludovico Einaudi and World music (flow type for relaxation)
Have read many motivational books but currently trying (no time) to read Norman Swan’s What is good for you.
has just received accreditation from the TGA.
Favourite movie of the past decade?
Too many favourites especially from Australian cinema, such as The Castle and Muriel’s Wedding. One of my current favourites is Contagion with Matt Damon and Gwyneth Paltrow, and how real that fictional plot has become.
What are you excited about in 2022?
The thought of growing CPL and getting more services up and running and enhancing processes excites me.
- Connect with Rima on LinkedIn
- Visit Central Pharmacy Logistics website